CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Growth in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 20,112 shares, a growth of 228.9% from the June 15th total of 6,115 shares. Based on an average trading volume of 348 shares, the days-to-cover ratio is presently 57.8 days.

CellaVision AB (publ) Price Performance

CLVSF stock opened at $14.00 on Tuesday. The company has a fifty day moving average price of $13.57 and a 200-day moving average price of $15.29. CellaVision AB has a 52-week low of $13.49 and a 52-week high of $17.30.

About CellaVision AB (publ)

(Get Free Report)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.

See Also

• Five stocks we like better than CellaVision AB (publ)
• CEOs Sell Millions Worth of These 3 Big Name Stocks—What It Means for Investors
• Fission for Profits: Unlocking America’s Uranium Vault
• The SK Hynix IPO and 2027’s AI Memory Squeeze
• Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts

Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.